Poujoulat SA (LON:0AB0)
London · Delayed Price · Currency is GBP · Price in EUR 6.70
0.00 (0.00%)
At close: Dec 9, 2025
Poujoulat Revenue
In the fiscal year ending March 31, 2025, Poujoulat had annual revenue of 349.41M EUR, down -0.87%. Poujoulat had revenue of 188.92M in the half year ending March 31, 2025, a decrease of -19.19%.
Revenue
349.41M EUR
Revenue Growth
-0.87%
P/S Ratio
0.16
Revenue / Employee
217.97K EUR
Employees
1,603
Market Cap
46.10M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 349.41M | -3.08M | -0.87% |
| Mar 31, 2024 | 352.49M | -49.58M | -12.33% |
| Mar 31, 2023 | 402.07M | 99.79M | 33.01% |
| Mar 31, 2022 | 302.28M | 56.91M | 23.19% |
| Mar 31, 2021 | 245.38M | 3.37M | 1.39% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |